Ceflatonin
information and resources from the National Cancer Institute
NCI Thesaurus | Ceflatonin
(Other name for: homoharringtonine)NCI Thesaurus | Ceflatonin
(Other name for: homoharringtonine)
|
|
|
|
news articles
FDA Orphan Drug Approvals: Ceflatonin, Valortim, TQ-1018 Mar 31, 2006
Medscape (subscription) On March 19, the FDA approved orphan drug status for homoharringtonine (HHT; Ceflatonin, made by ChemGenex Pharmaceuticals Ltd) in the treatment of chronic ...
ChemGenex Gets Ceflatonin Orphan Status Mar 20, 2006
MSN Money Pharmaceuticals Ltd. said late Sunday that the Food and Drug Administration granted orphan drug status to its cancer drug Ceflatonin. The ...
Orphan Drug Designation Granted by the US FDA for Ceflatonin(R) Mar 19, 2006
Boursorama, ...today that the United States Food and Drug Administration (FDA) has granted Orphan Drug status for the company's most advanced drug, Ceflatonin, for the ...
New Preclinical Research Supports Ceflatonin(R) in Treatment of ... Mar 22, 2006
International News Service, Pharmaceuticals Limited announced today the publication of pre-clinical research supporting the expansion of its clinical development of Ceflatonin to include ...
ChemGenex Pharmaceuticals receives US orphan drug designation for ... Mar 21, 2006
News-Medical.net, ...announced that the United States Food and Drug Administration (FDA) has granted Orphan Drug status for the company's most advanced drug, Ceflatonin, for the ...
FDA Grants Orphan Drug Status To ChemGenex Pharma's Ceflatonin For ... Mar 19, 2006
Trading Markets, Sunday evening, ChemGenex Pharmaceuticals Limited (CXSP | charts | news | Powerrating), a pharmaceutical development company, revealed that Ceflatonin has been ...
ChemGenex Pharma's Ceflatonin Wins Orphan Drug Status From FDA ... Mar 19, 2006
Trading Markets, ...(CXSP | charts | news | Powerrating) said that it has received the orphan drug status for its drug - Ceflatonin - from the FDA. ...
New Preclinical Research Supports Ceflatonin in Treatment of Acute ... Mar 23, 2006
PharmaLive.com (press release), ASX:CXS and NASDAQ:CXSP) announced today the publication of pre-clinical research supporting the expansion of its clinical development of Ceflatonin to include ...
New Preclinical Research Supports Ceflatonin in Treatment of Acute ... Mar 23, 2006
DG News Limited announced today the publication of pre-clinical research supporting the expansion of its clinical development of Ceflatonin (homoharringtonine) to ...
ChemGenex (CXSP) Granted Orphan Drug Status for Ceflatonin Mar 19, 2006
StreetInsider.com (subscription), Late Sunday, ChemGenex Pharmaceuticals Limited (Nasdaq: CXSP) announced the FDA has granted Orphan Drug status for its ... StreetInsider ...
ChemGenex Leukemia Drug Given Orphan Status in US Mar 20, 2006
International News Service, The FDA has granted orphan drug status for ChemGenex Pharmaceuticals' most advanced drug, Ceflatonin, for the treatment of chronic myeloid leukemia. ...
Path cleared for drug Mar 20, 2006
Geelong Advertiser, ...market. The American Food and Drug Administration has granted the company's most advanced drug, Ceflatonin, orphan drug status. ...
ChemGenex leukemia drug gets orphan nod Mar 20, 2006
United Press International MELBOURNE, March 20 (UPI) -- ChemGenex Pharmaceuticals said Monday its drug Ceflatonin for chronic myeloid leukemia has been given orphan drug status. ...
ChemGenex Leukemia Drug Gets Orphan Nod Mar 20, 2006
International News Service, ChemGenex Pharmaceuticals said Monday its drug Ceflatonin for chronic myeloid leukemia has been given orphan drug status. The company ...
Cowen & Co. 26th Annual Health Care Conference to Webcast ... Mar 5, 2006
PR Newswire (press release), ...presentation will provide an overview of ChemGenex's development pipeline, focusing on recent advances in the company's clinical programs, Ceflatonin(R) (HHT ...
Today's Small-Cap Winners and Losers Mar 23, 2006
TheStreet.com Take) was climbing after the company announced the publication of preclinical research supporting the expansion of its development of Ceflatonin to include the ...
Has Anyone Else Overlooked ChemGenex? Mar 21, 2006
Australasian Investment Review, The company announced earlier this week US regulator FDA has granted "Orphan Drug" status for its lead compound called Ceflatonin, which may offer a medical ...
(PRN) - XRT Releases 2005 Consolidated Results ... [+] Mar 19, 2006
Bolsamania.com, ...[+]. (PRN) - Orphan Drug Designation Granted by the US FDA for Ceflatonin(R) ... [. PRN) - American Capital Announces Public Offering of Common Stock ... [+. ...
(PRN) - Hallmark Financial Services, Inc. Announces Promotion of ... Mar 22, 2006
Bolsamania.com, 2006: Texas ... [+. PRN) - New Preclinical Research Supports Ceflatonin(R) in Treatment of Acute Myeloid Leukemia (AML) ... [. PRN ...
Gold Coast Bulletin (Australia) - Mar. 24, 2006 Mar 24, 2006
Therapeutics Daily (subscription) (press release), The research into ChemGenex Ceflatonin was published in the March, 2006, issue of Molecular Cancer Therapeutics from research performed by Dr Jean-Pierre Marie ...
Cowen & Co. 26th Annual Health Care Conference to Webcast ... Mar 6, 2006
Yahoo! News (press release) ...will provide an overview of ChemGenex's development pipeline, focusing on recent advances in the company's clinical programs, Ceflatonin® (HHT), in phase 2/3 ...
ChemGenex Reports Compelling Phase 2 Data Published In Leading ... Dec 11, 2005
PR Newswire (press release), Pharmaceuticals Limited (ASX: CXS; Nasdaq: CXSP) announced today that two abstracts related to the clinical development of Ceflatonin(R) (homoharringtonine, or ...
ChemGenex Reports Compelling Phase 2 Data Published In Leading ... Dec 11, 2005
Yahoo! News (press release) Limited (ASX: CXS - News; Nasdaq: CXSP - News) announced today that two abstracts related to the clinical development of Ceflatonin® (homoharringtonine, or ...
ChemGenex Reports Compelling Phase 2 Data Published In Leading ... Dec 12, 2005
PharmaLive.com (press release), FirstCall/ -- ChemGenex Pharmaceuticals Limited announced today that two abstracts related to the clinical development of Ceflatonin(R) (homoharringtonine, or ...
Frost & Sullivan honors ChemGenex with the 2005 Growth Strategy ... Dec 7, 2005
The Open Press (press release) ChemGenex currently has two compounds in Phase 2 clinical trials, Ceflatonin® for leukemia and Quinamed® for solid tumors, and has a significant portfolio of ...
BMS' dasatinib expected to rival Gleevec Nov 21, 2005
Science Daily (press release) ...launched, Decision Resources said, they will likely have a negative impact on the development of other CML medications, such as ChemGenex's Ceflatonin and Cell ...
|
|
